Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography

Journal of the American College of Cardiology

Volumn 28, Issue 3, 1996, Pages 757-762

  Muzik, Otto ^a   Paridon, Stephen M ^a   Singh, Tajinder P ^a   Morrow, W Robert ^a   Dayanikli, Firat ^b   Di Carli, Marcelo F ^a,c  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; EXERCISE TEST; FEMALE; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030245697     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00199-4     Document Type: Article

References (31)

1. 1. Newburger J, Takahashi M, Beiser A, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
2. 2. Kato H, Inoue O, Kagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev 1988;9:209-17.
3. 3. Paridon S, Galioto F, Vincent J, Tomassoni T, Sullivan N, Bricker J. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol 1995;25:1420-4.
4. 4. Fukazawa M, Fukushige J, Takeuchi T, et al. Discordance between thallium201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram. Pediatr Cardiol 1993;14:67-74.
5. 5. Schelbert H, Phelps M, Huang S, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259-72.
6. 6. Krivokapich J, Smith GT, Huang SC, et al. N-13 ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989;80:1328-37.
7. 7. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Non-invasive quantification of regional myocardial blood flow in the human heart using N-13 ammonia and dynamic positron emission tomography imaging. J Am Coll Cardiol 1990;15:1032-42.
8. 8. Schelbert HR, Wisenberg G, Phelps ME, et al. Non-invasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in man with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol 1982;49;1197-1209.
9. 9. Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 1989;79:825-35.
10. 10. Albro P, Gould K, Westcott R, Hamilton G, Ritchie J, Williams D. Noninvasive assessment of coronary stenosis by myocardial perfusion imaging during pharmacologic coronary vasodilation. III. Clinical trial. Am J Cardiol 1978;42:751-60.
11. 11. Di Carli M, Czernin J, Hoh C, et al. Relationship between stenosis severity, myocardial blood flow and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944-51.
12. 12. Gould K. Clinical cardiac positron emission tomography: state of the art. Circulation 1991;84 Suppl 3:122-36.
13. 13. DiCarli M, Sherman T, Khanna S, et al. Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:860-8.
14. 14. Muzik O, Beanlands R, Wolfe E, Hutchins G, Schwaiger M. Automated region definition for cardiac N-13 ammonia PET imaging. J Nucl Med 1993;34:336-44.
15. 15. Hutchins G, Caraher J, Raylman R. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med 1992;33:1243-50.
16. 16. Muzik O, Beanlands R, Hutchins G, Mangner T, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993;34:83-91.
17. 17. Czernin J, Muller P, Chan S, et al. Influence of age in hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88:62-9.
18. 18. Suzuki A, Yamagishi M, Kimura K, et al. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol 1996;27:291-6.
19. 19. Fujiwara T, Fujiwara H, Nakano H. Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Circulation 1988;78:345-50.
20. 20. Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986;73:444-51.
21. 21. Ettedgui JA, Neches WH, Pahl E. The role of cross-sectional echocardiography in Kawasaki disease. Cardiol Young 1991;1:221-4.
22. 22. Capannari T, Daniels S, Meyer R, Schwartz D, Kaplan S. Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 1986;7:355-60.
23. 23. Sugimura T, Kato H, Inoue O, et al. Intravascular ultrasound of coronary arteries in children. Circulation 1994;89:258-65.
24. 24. Uren N, Melin J, DeBruyne B, Wijns W, Baudhuin T, Camici P. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.
25. 25. Bache R, Cobb F. Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog. Circ Res 1977; 41:648-53.
26. 26. McGinn A, White C, Wilson R. Interstudy variability of coronary flow reserve: influence of heart rate, arterial pressure, and ventricular preload. Circulation 1990;81:1319-30.
27. 27. Rossen J, Winniford M. Effect of increases in heart rate and arterial pressure on coronary flow reserve in humans. J Am Coll Cardiol 1993;21:343-8.
28. 28. Mosher P, Ross JJ, McFate P, Shaw R. Control of coronary blood flow by an autoregulatory mechanism. Circ Res 1964; 14:250-6.
29. 29. Marzilli M, Goldstein S, Sabbah H, Lee T, Stein P. Modulating effect of regional myocardial performance on local myocardial perfusion in the dog. Circ Res 1979;45:634-41.
30. 30. Choi SY, Brunken RC, Czernin J, et al. Comparison of maximal blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992;20:979-85.
31. 31. Sawada S, Muzik O, Beanlands R, Wolfe E, Hutchins G, Schwaiger M. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography. J Nucl Cardiol 1995;2:413-22.